Risk assessment models to evaluate the necessity of prostate biopsies in North Chinese patients with 4-50 ng/mL PSA

BACKGROUND: Prostate-specific antigen (PSA) is widely used for prostate cancer screening, but low specificity results in high false positive rates of prostate biopsies. OBJECTIVE: To develop new risk assessment models to overcome the diagnostic limitation of PSA and reduce unnecessary prostate biops...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jing, Liu, Shuai, Gao, Dexuan, Ding, Sentai, Niu, Zhihong, Zhang, Hui, Huang, Zhilong, Qiu, Juhui, Li, Qing, Li, Ning, Xie, Fang, Cui, Jilei, Lu, Jiaju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354782/
https://www.ncbi.nlm.nih.gov/pubmed/28039477
http://dx.doi.org/10.18632/oncotarget.14214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354782/
https://www.ncbi.nlm.nih.gov/pubmed/28039477
http://dx.doi.org/10.18632/oncotarget.14214

Ejemplares similares